A study called SYNVEST is using advanced brain imaging to look at whether psychedelics actually change the density of connections between brain cells by acting on a specific receptor called 5-HT2A (a docking point on brain cells that psychedelics latch onto). The scans will likely show that yes, something measurable changes in the brain. But researchers won't be able to clearly show that more brain-connection changes equals more symptom relief in patients — which is the headline the field was hoping to prove.
Consensus of 2 agents: neuroscientist, fda_reviewer. 1 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →